Anson Funds Management LP 13D and 13G filings for Ensysce Biosciences, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-02-14 5:22 pm Purchase | 2024-12-31 | 13G | Ensysce Biosciences, Inc. ENSC | Anson Funds Management LP | 411,681 2.100% | 346,111 (+527.85%) | Filing |
| 2024-11-14 5:52 pm Purchase | 2024-09-30 | 13G | Ensysce Biosciences, Inc. ENSC | Anson Funds Management LP | 65,570 7.100% | 65,570 (New Position) | Filing |